Stereotactic Body Radiotherapy (SBRT) for Operable Stage I Non–Small-Cell Lung Cancer: Can SBRT Be Comparable to Surgery?
Top Cited Papers
- 1 December 2011
- journal article
- research article
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 81 (5), 1352-1358
- https://doi.org/10.1016/j.ijrobp.2009.07.1751
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- A Japanese Lung Cancer Registry Study: Prognosis of 13,010 Resected Lung CancersJournal of Thoracic Oncology, 2008
- High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non–small-cell lung cancer: Long-term results of a radiation dose escalation studyInternational Journal of Radiation Oncology*Biology*Physics, 2005
- Results following treatment to doses of 92.4 or 102.9 Gy on a phase I dose escalation study for non-small cell lung cancerLung Cancer, 2004
- Prognosis and survival after resection for bronchogenic carcinoma based on the 1997 TNM-staging classification: the Japanese experienceThe Annals of Thoracic Surgery, 2001
- A new approach to dose escalation in non–small-cell lung cancerInternational Journal of Radiation Oncology*Biology*Physics, 2001
- The international system for staging lung cancerSeminars in Surgical Oncology, 2000
- Limited field irradiation for medically inoperable patients with peripheral stage I non-small cell lung cancerLung Cancer, 1999
- Radiotherapy Alone for Medically Inoperable Stage I Non-Small–Cell Lung Cancer: The Duke ExperienceInternational Journal of Radiation Oncology*Biology*Physics, 1998
- Hyperfractionated radiotherapy alone for clinical stage I nonsmall cell lung cancerInternational Journal of Radiation Oncology*Biology*Physics, 1997
- Local irradiation alone for peripheral Stage I lung cancer: Could we omit the elective regional nodal irradiation?International Journal of Radiation Oncology*Biology*Physics, 1996